System and method for removing artifacts from waveforms
-
0Associated
Cases -
0Associated
Defendants -
0Accused
Products -
1Forward
Citation -
0
Petitions -
3
Assignments
First Claim
1. A method for processing a physiological signal, the method performed on a processing component and comprising the acts of:
- independently, identifying one or more artifacts in a physiological signal and performing one or more multi-resolution decompositions on the physiological signal to generate two or more decomposition products;
compensating for the one or more artifacts in the two or more decomposition products to generate modified decomposition products;
generating an artifact-compensated signal based on the modified decomposition products;
processing the artifact-compensated signal at a monitor to derive one or more physiological characteristics of interest; and
displaying the one or more physiological characteristics on the monitor.
3 Assignments
0 Petitions

Accused Products

Abstract
A technique is provided for processing a physiological signal to compensate for artifacts. The technique includes identifying artifacts within the physiological signal. The technique also includes performing one or more multi-resolution decompositions, such as wavelet transformations, on the physiological signal and compensating for the identified artifacts in some or all of the respective decomposition components. The modified decomposition components may be reconstructed to generate an artifact-compensated signal which may be provided to a monitor or other device which is otherwise not configured to compensate for signal artifacts.
247 Citations
Real-time processing of handstate representation model estimates | ||
Patent #
US 10,460,455 B2
Filed 01/25/2019
|
Current Assignee
CTRL-LABS CORPORATION
|
Sponsoring Entity
CTRL-LABS CORPORATION
|
SIGNAL PROCESSING APPARATUS | ||
Patent #
US 20080004514A1
Filed 06/21/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Signal processing apparatus | ||
Patent #
US 7,328,053 B1
Filed 11/17/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 20080033266A1
Filed 08/20/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Photoplethysmography (PPG) device and the method thereof | ||
Patent #
US 7,336,982 B2
Filed 07/07/2004
|
Current Assignee
Silicon Mitus Inc.
|
Sponsoring Entity
Yoo Sun Kook
|
SIGNAL PROCESSING APPARATUS | ||
Patent #
US 20080045823A1
Filed 08/20/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
SIGNAL PROCESSING APPARATUS AND METHOD | ||
Patent #
US 20080036752A1
Filed 08/20/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Blind source separation of pulse oximetry signals | ||
Patent #
US 7,343,187 B2
Filed 12/27/2005
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett LLC
|
Signal processing apparatus | ||
Patent #
US 7,376,453 B1
Filed 09/01/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry data capture system | ||
Patent #
US 7,373,193 B2
Filed 11/05/2004
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing apparatus | ||
Patent #
US 7,383,070 B2
Filed 12/03/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry relational alarm system for early recognition of instability and catastrophic occurrences | ||
Patent #
US 7,398,115 B2
Filed 06/09/2005
|
Current Assignee
Lawrence A. Lynn
|
Sponsoring Entity
Lawrence A. Lynn
|
Internal medical device communication bus | ||
Patent #
US 7,162,306 B2
Filed 11/19/2001
|
Current Assignee
Physio-Control Incorporated
|
Sponsoring Entity
Physio-Control Incorporated
|
Wavelet transform of a plethysmographic signal | ||
Patent #
US 20070004977A1
Filed 06/29/2005
|
Current Assignee
General Electric Company
|
Sponsoring Entity
General Electric Company
|
System and method for pre-processing waveforms | ||
Patent #
US 20070073120A1
Filed 09/29/2005
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Ear type apparatus for measuring a bio signal and measuring method therefor | ||
Patent #
US 7,209,775 B2
Filed 04/15/2004
|
Current Assignee
Samsung Electronics Co. Ltd.
|
Sponsoring Entity
Samsung Electronics Co. Ltd.
|
Signal processing apparatus | ||
Patent #
US 7,215,986 B2
Filed 06/15/2005
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Adaptive prediction of changes of physiological/pathological states using processing of biomedical signals | ||
Patent #
US 7,225,013 B2
Filed 10/03/2003
|
Current Assignee
WIDEMED TECHNOLOGIES LTD.
|
Sponsoring Entity
WIDEMED LTD.
|
Signal processing apparatus | ||
Patent #
US 7,215,984 B2
Filed 05/04/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Device and method for monitoring body fluid and electrolyte disorders | ||
Patent #
US 7,236,811 B2
Filed 05/20/2003
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett LLC
|
Venous pulse oximetry | ||
Patent #
US 7,263,395 B2
Filed 01/31/2003
|
Current Assignee
HU SIJUNG DR
|
Sponsoring Entity
LOUGHBOROUGH UNIVERSITY ENTERPRISES LTD.
|
Signal processing apparatus | ||
Patent #
US 7,254,433 B2
Filed 09/30/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
SIGNAL PROCESSING APPARATUS | ||
Patent #
US 20070225581A1
Filed 05/25/2007
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
RESPIRATION-BASED PROGNOSIS OF HEART DISEASE | ||
Patent #
US 20070213622A1
Filed 05/17/2007
|
Current Assignee
WIDEMED TECHNOLOGIES LTD.
|
Sponsoring Entity
WIDEMED TECHNOLOGIES LTD.
|
DETECTION OF HEART FAILURE USING A PHOTOPLETHYSMOGRAPH | ||
Patent #
US 20070213621A1
Filed 05/17/2007
|
Current Assignee
WIDEMED TECHNOLOGIES LTD.
|
Sponsoring Entity
WIDEMED TECHNOLOGIES LTD.
|
Finger medical sensor | ||
Patent #
US 7,272,426 B2
Filed 01/30/2004
|
Current Assignee
Koninklijke Philips N.V.
|
Sponsoring Entity
Koninklijke Philips N.V.
|
SIGNAL PROCESSING APPARATUS | ||
Patent #
US 20070249918A1
Filed 06/21/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
SIGNAL PROCESSING APPARATUS | ||
Patent #
US 20070291832A1
Filed 06/21/2007
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Method of facilitating the operation of terminals intelecommunications systems | ||
Patent #
US 5,831,598 A
Filed 12/05/1996
|
Current Assignee
Alcatel SA
|
Sponsoring Entity
Alcatel SA
|
Probe for use in non-invasive measurements of blood related parameters | ||
Patent #
US 6,983,178 B2
Filed 03/15/2001
|
Current Assignee
ORSENSE LTD.
|
Sponsoring Entity
ORSENSE LTD.
|
Optical apparatus and method of use for non-invasive tomographic scan of biological tissues | ||
Patent #
US 20060015021A1
Filed 06/29/2004
|
Current Assignee
02 MEDTECH INC.
|
Sponsoring Entity
02 MEDTECH INC.
|
Multi-wavelength physiological monitor | ||
Patent #
US 20060009688A1
Filed 05/27/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry SpO2 determination | ||
Patent #
US 6,987,994 B1
Filed 11/03/2003
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Pulse oximetry sensor adaptor | ||
Patent #
US 6,993,371 B2
Filed 07/22/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Device and method for monitoring body fluid and electrolyte disorders | ||
Patent #
US 20060020181A1
Filed 09/30/2005
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Pulse oximetry data confidence indicator | ||
Patent #
US 6,996,427 B2
Filed 12/18/2003
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter sensor with piece-wise function | ||
Patent #
US 20060030763A1
Filed 09/30/2005
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Optical examination of biological tissue using non-contact irradiation and detection | ||
Patent #
US 20060058683A1
Filed 08/13/2005
|
Current Assignee
Chance Britton
|
Sponsoring Entity
Chance Britton
|
Body surface probe, apparatus and method for non-invasively detecting medical conditions | ||
Patent #
US 20060064024A1
Filed 01/18/2005
|
Current Assignee
ITAMAR MEDICAL LTD.
|
Sponsoring Entity
ITAMAR MEDICAL LTD.
|
Pulse and active pulse spectraphotometry | ||
Patent #
US 20060052680A1
Filed 10/31/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Separating motion from cardiac signals using second order derivative of the photo-plethysmogram and fast fourier transforms | ||
Patent #
US 7,020,507 B2
Filed 01/30/2003
|
Current Assignee
Spacelabs Healthcare Incorporated
|
Sponsoring Entity
Dolphin Medical Inc.
|
Parallel measurement alarm processor | ||
Patent #
US 7,030,749 B2
Filed 10/28/2004
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Blood parameter measurement system | ||
Patent #
US 7,027,849 B2
Filed 11/21/2003
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Masimo Laboratories Inc.
|
Specially configured nasal pulse oximeter/photoplethysmography probes, and combined nasal probe/cannula, selectively with sampler for capnography, and covering sleeves for same | ||
Patent #
US 7,024,235 B2
Filed 12/30/2003
|
Current Assignee
Beta Biomed Services Inc., University of Florida Research Foundation Incorporated
|
Sponsoring Entity
Beta Biomed Services Inc., University of Florida Research Foundation Incorporated
|
Wavelet-based analysis of pulse oximetry signals | ||
Patent #
US 7,035,679 B2
Filed 06/21/2002
|
Current Assignee
Nellcor Puritan Bennett Ireland
|
Sponsoring Entity
CardioDigital Ltd.
|
Access control systems and methods for motion control | ||
Patent #
US 7,035,697 B1
Filed 02/22/2005
|
Current Assignee
Automation Middleware Solutions Inc.
|
Sponsoring Entity
ROY-G-BIV Corporation
|
Hat-based oximeter sensor | ||
Patent #
US 7,047,056 B2
Filed 06/25/2003
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Method, apparatus and system for removing motion artifacts from measurements of bodily parameters | ||
Patent #
US 7,072,702 B2
Filed 06/22/2004
|
Current Assignee
Philips Electronics North America Corporation
|
Sponsoring Entity
RIC INVESTMENTS LLC
|
Blind source separation of pulse oximetry signals | ||
Patent #
US 7,079,880 B2
Filed 09/29/2003
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett LLC
|
Hat-based oximeter sensor | ||
Patent #
US 20060195028A1
Filed 02/21/2006
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Separating motion from cardiac signals using second order derivative of the photo-plethysmogram and fast fourier transforms | ||
Patent #
US 20060211930A1
Filed 01/30/2006
|
Current Assignee
Spacelabs Healthcare Incorporated
|
Sponsoring Entity
Spacelabs Healthcare Incorporated
|
Signal processing apparatus | ||
Patent #
US 20060217609A1
Filed 05/11/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Signal processing apparatus and method | ||
Patent #
US 20060200016A1
Filed 05/03/2006
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Pulse oximetry sensor and technique for using the same on a distal region of a patient's digit | ||
Patent #
US 20060224058A1
Filed 03/31/2005
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Specially configured lip/cheek pulse oximeter/photoplethysmography probes, selectively with sampler for capnography, and covering sleeves for same | ||
Patent #
US 7,127,278 B2
Filed 01/02/2004
|
Current Assignee
University of Florida Research Foundation Incorporated
|
Sponsoring Entity
Beta Biomed Services Inc.
|
System and method for detecting signal artifacts | ||
Patent #
US 20060247501A1
Filed 08/06/2004
|
Current Assignee
Koninklijke Philips N.V.
|
Sponsoring Entity
Koninklijke Philips N.V.
|
Method of analyzing and processing signals | ||
Patent #
US 20060258921A1
Filed 02/27/2004
|
Current Assignee
Nellcor Puritan Bennett Ireland
|
Sponsoring Entity
Nellcor Puritan Bennett Ireland
|
Method, apparatus, and system for removing motion artifacts from measurements of bodily parameters | ||
Patent #
US 20060258927A1
Filed 04/21/2006
|
Current Assignee
Reuben W. Edgar Jr., DelFavero John R., Jaffe Michael B., Gunneson Paul B., Allo August J. Jr., Martin Jesus D.
|
Sponsoring Entity
Reuben W. Edgar Jr., DelFavero John R., Jaffe Michael B., Gunneson Paul B., Allo August J. Jr., Martin Jesus D.
|
Separating oximeter signal components based on color | ||
Patent #
US 20060293574A1
Filed 10/14/2005
|
Current Assignee
General Electric Company
|
Sponsoring Entity
General Electric Company
|
Device for measuring the motion of a conducting body through magnetic induction | ||
Patent #
US 6,850,053 B2
Filed 08/07/2002
|
Current Assignee
Siemens AG
|
Sponsoring Entity
Siemens AG
|
Method, apparatus and system for removing motion artifacts from measurements of bodily parameters | ||
Patent #
US 20050033129A1
Filed 06/22/2004
|
Current Assignee
Philips Electronics North America Corporation
|
Sponsoring Entity
Philips Electronics North America Corporation
|
Power conserving adaptive control system for generating signal in portable medical devices | ||
Patent #
US 6,863,652 B2
Filed 03/10/2003
|
Current Assignee
Draeger Medical Systems Incorporated
|
Sponsoring Entity
Draeger Medical Systems Incorporated
|
Multi-domain motion estimation and plethysmographic recognition using fuzzy neural-nets | ||
Patent #
US 20050049470A1
Filed 08/27/2004
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Method and apparatus for non-invasive blood constituent monitoring | ||
Patent #
US 6,873,865 B2
Filed 12/12/2003
|
Current Assignee
Hema Metrics LLC
|
Sponsoring Entity
Hema Metrics Inc.
|
Apparatus for evaluating biological function | ||
Patent #
US 20050080323A1
Filed 08/11/2004
|
Current Assignee
Kato Toshinori
|
Sponsoring Entity
Kato Toshinori
|
Hemoglobinometers and the like for measuring the metabolic condition of a subject | ||
Patent #
US 20050113656A1
Filed 08/30/2004
|
Current Assignee
Chance Britton
|
Sponsoring Entity
Chance Britton
|
Optical device | ||
Patent #
US 20050101850A1
Filed 11/22/2004
|
Current Assignee
WHITLAND RESEARCH LIMITED
|
Sponsoring Entity
WHITLAND RESEARCH LIMITED
|
Non-invasive blood analyte measuring system and method utilizing optical absorption | ||
Patent #
US 6,898,451 B2
Filed 03/21/2002
|
Current Assignee
MINFORMED L.L.C.
|
Sponsoring Entity
MINFORMED L.L.C.
|
Apparatus and method for surgical planning and treatment monitoring | ||
Patent #
US 20050113651A1
Filed 11/19/2004
|
Current Assignee
Merge CAD Inc.
|
Sponsoring Entity
Merge CAD Inc.
|
System and method for a self-calibrating non-invasive sensor | ||
Patent #
US 6,889,153 B2
Filed 08/09/2001
|
Current Assignee
Measurement Specialties Incorporated
|
Sponsoring Entity
Measurement Specialties Incorporated
|
Multi-domain motion estimation and plethysmographic recognition using fuzzy neural-nets | ||
Patent #
US 6,931,269 B2
Filed 08/27/2004
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Device and method for measuring constituents in blood | ||
Patent #
US 20050168722A1
Filed 02/08/2003
|
Current Assignee
MCC GESELLSCHAFT FUR DIAGNOSESYSTEME IN MEDIZIN UND TECHNIK MBH CO. KG
|
Sponsoring Entity
MCC GESELLSCHAFT FUR DIAGNOSESYSTEME IN MEDIZIN UND TECHNIK MBH CO. KG
|
Ear canal sensing device | ||
Patent #
US 20050177034A1
Filed 03/03/2003
|
Current Assignee
Terry Beaumont
|
Sponsoring Entity
Terry Beaumont
|
Non-invasive blood analyte measuring system and method utilizing optical absorption | ||
Patent #
US 20050192493A1
Filed 05/02/2005
|
Current Assignee
Minformed L.L.C.
|
Sponsoring Entity
Minformed L.L.C.
|
Auditory alarms for physiological data monitoring | ||
Patent #
US 6,947,780 B2
Filed 03/31/2003
|
Current Assignee
Spacelabs Healthcare Incorporated
|
Sponsoring Entity
Dolphin Medical Inc.
|
Sensing and interactive drug delivery | ||
Patent #
US 6,949,081 B1
Filed 08/26/1999
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NON-INVASIVE TECHNOLOGY INC.
|
Non-invasive method and apparatus for determining a physiological parameter | ||
Patent #
US 20050192488A1
Filed 02/11/2005
|
Current Assignee
Biopeak Corporation
|
Sponsoring Entity
Biopeak Corporation
|
Signal processing apparatus | ||
Patent #
US 20050209517A1
Filed 03/02/2005
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Pulse oximetry motion artifact rejection using near infrared absorption by water | ||
Patent #
US 20050203357A1
Filed 03/09/2004
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Method and apparatus for monitoring haemodynamic function | ||
Patent #
US 6,939,307 B1
Filed 05/13/1998
|
Current Assignee
Dunlop Colin
|
Sponsoring Entity
Dunlop Colin
|
Clip-type sensor having integrated biasing and cushioning means | ||
Patent #
US 20050228248A1
Filed 04/07/2004
|
Current Assignee
Measurement Specialties Incorporated
|
Sponsoring Entity
Measurement Specialties Incorporated
|
Pulse and active pulse spectraphotometry | ||
Patent #
US 6,961,598 B2
Filed 02/21/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Non-invasive blood component measurement system | ||
Patent #
US 20050267346A1
Filed 01/31/2005
|
Current Assignee
3WAVE OPTICS LLC
|
Sponsoring Entity
3WAVE OPTICS LLC
|
Fetal oximetry system and sensor | ||
Patent #
US 20050283059A1
Filed 10/01/2004
|
Current Assignee
RIC INVESTMENTS LLC
|
Sponsoring Entity
RIC INVESTMENTS LLC
|
Optical probe and positioning wrap | ||
Patent #
US 6,678,543 B2
Filed 11/08/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry data confidence indicator | ||
Patent #
US 6,684,090 B2
Filed 05/15/2001
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Signal processing method and device for signal-to-noise improvement | ||
Patent #
US 20040010188A1
Filed 06/19/2003
|
Current Assignee
Conmed Corporation
|
Sponsoring Entity
Conmed Corporation
|
Ultrasound-guided near infrared spectrophotometer | ||
Patent #
US 6,690,958 B1
Filed 05/07/2002
|
Current Assignee
Nostix LLC
|
Sponsoring Entity
Nostix LLC
|
Low power pulse oximeter | ||
Patent #
US 6,697,658 B2
Filed 06/26/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Apparatus and method for monitoring tissue vitality parameters | ||
Patent #
US 20040054270A1
Filed 03/25/2003
|
Current Assignee
CRITISENSE LTD.
|
Sponsoring Entity
CRITISENSE LTD.
|
Phase modulation spectrophotometric apparatus | ||
Patent #
US 6,708,048 B1
Filed 01/13/1999
|
Current Assignee
Non-Invasive Technology Inc.
|
Sponsoring Entity
Non-Invasive Technology Inc.
|
Blind source separation of pulse oximetry signals | ||
Patent #
US 6,701,170 B2
Filed 11/02/2001
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Wavelet depulsing of ultrasound echo sequences | ||
Patent #
US 20040054281A1
Filed 01/29/2003
|
Current Assignee
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
|
Sponsoring Entity
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
|
Blind source separation of pulse oximetry signals | ||
Patent #
US 20040059210A1
Filed 09/29/2003
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Pulse oximeter with calibration stabilization | ||
Patent #
US 6,711,425 B1
Filed 05/28/2002
|
Current Assignee
PROTHIA
|
Sponsoring Entity
OB SCIENTIFIC INC.
|
Video camera having a liquid-crystal monitor with controllable backlight | ||
Patent #
US 6,714,245 B1
Filed 03/16/1999
|
Current Assignee
Canon Ayutthaya Limited
|
Sponsoring Entity
Canon Ayutthaya Limited
|
Method of optical measurement for determing various parameters of the patient's blood | ||
Patent #
US 6,711,424 B1
Filed 11/05/2002
|
Current Assignee
ORSENSE LTD.
|
Sponsoring Entity
ORSENSE LTD.
|
Display brightness control method and apparatus for conserving battery power | ||
Patent #
US 6,731,274 B2
Filed 05/15/2003
|
Current Assignee
Gateway Incorporated
|
Sponsoring Entity
Gateway Incorporated
|
Signal processing method and device for signal-to-noise improvement | ||
Patent #
US 20040087846A1
Filed 07/23/2003
|
Current Assignee
Conmed Corporation
|
Sponsoring Entity
Conmed Corporation
|
Blood parameter measurement system | ||
Patent #
US 20040107065A1
Filed 11/21/2003
|
Current Assignee
Cercacor Laboratories
|
Sponsoring Entity
Cercacor Laboratories
|
Method and apparatus for non-invasive blood constituent monitoring | ||
Patent #
US 20040127779A1
Filed 12/12/2003
|
Current Assignee
Hema Metrics LLC
|
Sponsoring Entity
Hema Metrics LLC
|
Transcranial examination of the brain | ||
Patent #
US 6,785,568 B2
Filed 06/27/2002
|
Current Assignee
Non-Invasive Technology Inc.
|
Sponsoring Entity
Non-Invasive Technology Inc.
|
Optical feedback system for vision correction | ||
Patent #
US 6,793,654 B2
Filed 05/28/2002
|
Current Assignee
Amo Manufacturing Usa Llc
|
Sponsoring Entity
VISX Incorporated
|
Biomedical signal denoising techniques | ||
Patent #
US 20040193065A1
Filed 03/31/2003
|
Current Assignee
Medtronic Incorporated
|
Sponsoring Entity
-
|
Method of optical measurements for determining various parameters of the patient's blood | ||
Patent #
US 20040176671A1
Filed 03/22/2004
|
Current Assignee
ORSENSE LTD.
|
Sponsoring Entity
ORSENSE LTD.
|
Pulse oximeter sensor with piece-wise function | ||
Patent #
US 20040171920A1
Filed 03/10/2004
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Apparatus for measuring concentration of light-absorbing substance in blood | ||
Patent #
US 20040176670A1
Filed 02/02/2004
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
-
|
Body-member-illuminating pressure cuff for use in optical noninvasive measurement of blood parameters | ||
Patent #
US 6,801,798 B2
Filed 06/20/2002
|
Current Assignee
Purdue Research Foundation
|
Sponsoring Entity
Purdue Research Foundation
|
Pulse oximeter sensor with piece-wise function | ||
Patent #
US 6,801,797 B2
Filed 04/16/2001
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Method, apparatus and system for removing motion artifacts from measurements of bodily parameters | ||
Patent #
US 6,810,277 B2
Filed 08/06/2002
|
Current Assignee
Philips Electronics North America Corporation
|
Sponsoring Entity
RIC INVESTMENTS LLC
|
Pulse oximeter and method of operation | ||
Patent #
US 6,801,799 B2
Filed 02/06/2003
|
Current Assignee
T.M.M. ACQUISITIONS LTD.
|
Sponsoring Entity
T.M.M. ACQUISITIONS LTD.
|
Device and method for monitoring body fluid and electrolyte disorders | ||
Patent #
US 20040230106A1
Filed 10/30/2003
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Blood component measurement apparatus | ||
Patent #
US 6,829,496 B2
Filed 11/19/2002
|
Current Assignee
Minolta Corporation Limited
|
Sponsoring Entity
Minolta Corporation Limited
|
Pathlength corrected oximeter and the like | ||
Patent #
US 20030023140A1
Filed 06/18/2002
|
Current Assignee
Chance Britton
|
Sponsoring Entity
Chance Britton
|
Direct to digital oximeter and method for calculating oxygenation levels | ||
Patent #
US 6,526,301 B2
Filed 12/19/2000
|
Current Assignee
Indusind Bank Limited
|
Sponsoring Entity
Criticare Systems Inc.
|
Method, apparatus and system for removing motion artifacts from measurements of bodily parameters | ||
Patent #
US 6,519,486 B1
Filed 04/10/2000
|
Current Assignee
Philips Electronics North America Corporation
|
Sponsoring Entity
Respironics Incorporated
|
Apparatus and method for quantification of tissue hydration using diffuse reflectance spectroscopy | ||
Patent #
US 20030060693A1
Filed 06/25/2002
|
Current Assignee
GLT Acquisition Corporation
|
Sponsoring Entity
GLT Acquisition Corporation
|
Signal processing method and device for signal-to-noise improvement | ||
Patent #
US 20030055324A1
Filed 10/17/2001
|
Current Assignee
Conmed Corporation
|
Sponsoring Entity
Conmed Corporation
|
Biological sensor | ||
Patent #
US 6,546,267 B1
Filed 11/27/2000
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Spectrophotometer for tissue examination | ||
Patent #
US 6,549,795 B1
Filed 07/14/1998
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NON-INVASIVE TECHNOLOGY INC.
|
Noninvasive measurement of chemical substances | ||
Patent #
US 6,544,193 B2
Filed 02/23/2001
|
Current Assignee
Geelux Holdings Ltd.
|
Sponsoring Entity
Marcio Marc Abreu
|
Shielded optical probe and method | ||
Patent #
US 6,580,086 B1
Filed 10/19/1999
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Universal/upgrading pulse oximeter | ||
Patent #
US 6,584,336 B1
Filed 03/01/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximeter and method of operation | ||
Patent #
US 20030144584A1
Filed 02/06/2003
|
Current Assignee
T.M.M. ACQUISITIONS LTD.
|
Sponsoring Entity
-
|
Method and apparatus for determining oxygen saturation of blood in body organs | ||
Patent #
US 6,594,513 B1
Filed 01/12/2000
|
Current Assignee
Paul D. Jobsis
|
Sponsoring Entity
Paul D. Jobsis
|
Noninvasive measurement of chemical substances | ||
Patent #
US 20030139687A1
Filed 02/06/2003
|
Current Assignee
Geelux Holdings Ltd.
|
Sponsoring Entity
Geelux Holdings Ltd.
|
Device and method for monitoring body fluid and electrolyte disorders | ||
Patent #
US 6,591,122 B2
Filed 03/16/2001
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Pulse oximetry pulse indicator | ||
Patent #
US 6,606,511 B1
Filed 01/06/2000
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for improving the accuracy of noninvasive hematocrit measurements | ||
Patent #
US 6,606,509 B2
Filed 03/16/2001
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Non-invasive blood component analyzer | ||
Patent #
US 6,615,064 B1
Filed 02/28/2000
|
Current Assignee
Essential Medical Devices
|
Sponsoring Entity
Essential Medical Devices
|
Display brightness control method and apparatus for conserving battery power | ||
Patent #
US 6,618,042 B1
Filed 10/28/1999
|
Current Assignee
Gateway Incorporated
|
Sponsoring Entity
Gateway Incorporated
|
Apparatus for determining concentrations of hemoglobins | ||
Patent #
US 6,622,095 B2
Filed 02/15/2002
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Finger oximeter with finger grip suspension system | ||
Patent #
US 6,654,621 B2
Filed 08/29/2001
|
Current Assignee
Smiths Medical ASD Inc.
|
Sponsoring Entity
Smiths Medical MD Incorporated
|
Interference suppression for measuring signals with periodic wanted signals | ||
Patent #
US 6,654,623 B1
Filed 05/29/2002
|
Current Assignee
Koninklijke Philips N.V.
|
Sponsoring Entity
Koninklijke Philips N.V.
|
Cepstral domain pulse oximetry | ||
Patent #
US 6,650,918 B2
Filed 02/21/2003
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Pulse and active pulse spectraphotometry | ||
Patent #
US 20030220576A1
Filed 02/21/2003
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
-
|
Pulse oximeter probe-off detector | ||
Patent #
US 6,654,624 B2
Filed 12/19/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Device and method for monitoring body fluid and electrolyte disorders | ||
Patent #
US 20030220548A1
Filed 05/20/2003
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Diode detection circuit | ||
Patent #
US 6,668,183 B2
Filed 09/11/2001
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Non-invasive sensor having controllable temperature feature | ||
Patent #
US 6,662,030 B2
Filed 05/18/1998
|
Current Assignee
Abbott Laboratories Incorporated
|
Sponsoring Entity
Abbott Laboratories Incorporated
|
Probe and apparatus for determining concentration of light-absorbing materials in living tissue | ||
Patent #
US 6,671,526 B1
Filed 10/20/2000
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Signal processing method and device for signal-to-noise improvement | ||
Patent #
US 6,658,277 B2
Filed 10/17/2001
|
Current Assignee
Conmed Corporation
|
Sponsoring Entity
Conmed Corporation
|
Separating motion from cardiac signals using second order derivative of the photo-plethysmogram and fast fourier transforms | ||
Patent #
US 20030225337A1
Filed 01/30/2003
|
Current Assignee
Spacelabs Healthcare Incorporated
|
Sponsoring Entity
Spacelabs Healthcare Incorporated
|
Pulse oximeter user interface | ||
Patent #
US 6,658,276 B2
Filed 02/12/2002
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for non-invasive blood constituent monitoring | ||
Patent #
US 6,671,528 B2
Filed 01/30/2001
|
Current Assignee
Hema Metrics LLC
|
Sponsoring Entity
HEMA METRICS INC.
|
NON-INVASIVE SENSOR HAVING CONTROLLABLE TEMPERATURE FEATURE | ||
Patent #
US 20020026106A1
Filed 05/18/1998
|
Current Assignee
Abbott Laboratories Incorporated
|
Sponsoring Entity
Abbott Laboratories Incorporated
|
Living body inspecting apparatus and noninvasive blood analyzer using the same | ||
Patent #
US 6,353,750 B1
Filed 10/25/1999
|
Current Assignee
Sysmex Corporation
|
Sponsoring Entity
Sysmex Corporation
|
Pulse wave diagnosing device | ||
Patent #
US 6,361,501 B1
Filed 06/21/1999
|
Current Assignee
Seiko Epson Corporation
|
Sponsoring Entity
Seiko Epson Corporation
|
System for noninvasive hematocrit monitoring | ||
Patent #
US 20020038079A1
Filed 06/13/2001
|
Current Assignee
Fresenius Medical Care Holdings Incorporated
|
Sponsoring Entity
Fresenius Medical Care Holdings Incorporated
|
Pulse oximeter sensor with piece-wise function | ||
Patent #
US 20020035318A1
Filed 04/16/2001
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Pulse oximeter and method of operation | ||
Patent #
US 20020042558A1
Filed 08/24/2001
|
Current Assignee
CYBRO MEDICAL LTD.
|
Sponsoring Entity
CYBRO MEDICAL LTD.
|
Noninvasive measurement of chemical substances | ||
Patent #
US 20020049389A1
Filed 02/23/2001
|
Current Assignee
Geelux Holdings Ltd.
|
Sponsoring Entity
Geelux Holdings Ltd.
|
Manual and automatic probe calibration | ||
Patent #
US 6,397,091 B2
Filed 11/30/1999
|
Current Assignee
The United States of America As Represented By The Secretary of Agriculture
|
Sponsoring Entity
The United States of America As Represented By The Secretary of Agriculture
|
Manual and automatic probe calibration | ||
Patent #
US 20020062071A1
Filed 11/08/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
JP Morgan Chase Bank N.A.
|
Method, apparatus and system for removing motion artifacts from measurements of bodily parameters | ||
Patent #
US 6,393,311 B1
Filed 10/01/1999
|
Current Assignee
Philips Electronics North America Corporation
|
Sponsoring Entity
RIC INVESTMENTS LLC
|
Apparatus for determining concentrations of hemoglobins | ||
Patent #
US 6,415,236 B2
Filed 11/30/2000
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Optical feedback system for vision correction | ||
Patent #
US 6,419,671 B1
Filed 12/23/1999
|
Current Assignee
Amo Manufacturing Usa Llc
|
Sponsoring Entity
VISX Incorporated
|
Apparatus for determining concentrations of hemoglobins | ||
Patent #
US 20020111748A1
Filed 02/15/2002
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Multi-wavelength frequency domain near-infrared cerebral oximeter | ||
Patent #
US 6,438,399 B1
Filed 02/16/2000
|
Current Assignee
Childrens Hospital of Philadelphia
|
Sponsoring Entity
Childrens Hospital of Philadelphia
|
Compensation of human variability in pulse oximetry | ||
Patent #
US 20020133068A1
Filed 01/22/2001
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Transcranial examination of the brain | ||
Patent #
US 20020161290A1
Filed 06/27/2002
|
Current Assignee
Non-Invasive Technology Inc. a Delaware corporation
|
Sponsoring Entity
Non-Invasive Technology Inc. a Delaware corporation
|
Device and method for monitoring body fluid and electrolyte disorders | ||
Patent #
US 20020161287A1
Filed 03/16/2001
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Pulse oximetry sensor with improved spring | ||
Patent #
US 20020156354A1
Filed 04/20/2001
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Oximeter sensor having laminated housing with flat patient interface surface | ||
Patent #
US 6,466,809 B1
Filed 11/02/2000
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Pressure applicator devices particularly useful for non-invasive detection of medical conditions | ||
Patent #
US 6,461,305 B1
Filed 04/28/2000
|
Current Assignee
ITAMAR MEDICAL
|
Sponsoring Entity
ITAMAR MEDICAL
|
Method and apparatus for improving the accuracy of noninvasive hematocrit measurements | ||
Patent #
US 20020165439A1
Filed 03/16/2001
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Covidien PLC
|
Glove-mounted hybrid probe for tissue type recognition | ||
Patent #
US 6,487,439 B1
Filed 03/17/1997
|
Current Assignee
POLARTECHNICS LIMITED
|
Sponsoring Entity
POLARTECHNICS LIMITED
|
Signal processing apparatus and method | ||
Patent #
US 6,501,975 B2
Filed 01/09/2001
|
Current Assignee
JP Morgan Chase Bank N.A.
|
Sponsoring Entity
Masimo Corporation
|
Method and device for measuring blood sugar level | ||
Patent #
US 20020198443A1
Filed 05/17/2002
|
Current Assignee
Ting Choon Meng
|
Sponsoring Entity
Ting Choon Meng
|
Compensation of human variability in pulse oximetry | ||
Patent #
US 6,501,974 B2
Filed 01/22/2001
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Datex-Ohmeda Incorporated
|
Detection of parasitic signals during pulsoxymetric measurement | ||
Patent #
US 6,181,959 B1
Filed 03/25/1999
|
Current Assignee
Radiometer Basel AG
|
Sponsoring Entity
LINDE MEDICAL SENSORS AG
|
Method and apparatus for non-invasive blood constituent monitoring | ||
Patent #
US 6,181,958 B1
Filed 02/05/1999
|
Current Assignee
Hema Metrics LLC
|
Sponsoring Entity
HEMA METRICS INC.
|
Methods of enhancing optical signals by mechanical manipulation in non-invasive testing | ||
Patent #
US 6,222,189 B1
Filed 05/06/1998
|
Current Assignee
OPTIX LP
|
Sponsoring Entity
OPTIX LP
|
Apparatus for determining concentrations of light-absorbing materials in living tissue | ||
Patent #
US 6,230,035 B1
Filed 07/19/1999
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Direct to digital oximeter and method for calculating oxygenation levels | ||
Patent #
US 20010005773A1
Filed 12/19/2000
|
Current Assignee
Indusind Bank Limited
|
Sponsoring Entity
Indusind Bank Limited
|
System for noninvasive hematocrit monitoring | ||
Patent #
US 6,266,546 B1
Filed 05/28/1998
|
Current Assignee
Fresenius Medical Care Holdings Incorporated
|
Sponsoring Entity
HEMA METRICS INC.
|
System and method for measuring blood urea nitrogen, blood osmolarity, plasma free hemoglobin and tissue water content | ||
Patent #
US 20010020122A1
Filed 01/22/2001
|
Current Assignee
Hema Metrics LLC
|
Sponsoring Entity
Hema Metrics LLC
|
Measuring sensor for monitoring characteristics of a living tissue | ||
Patent #
US 6,285,895 B1
Filed 08/18/1998
|
Current Assignee
Instrumentarium Dental Incorporated
|
Sponsoring Entity
Instrumentarium Dental Incorporated
|
Contact device for placement in direct apposition to the conjunctive of the eye | ||
Patent #
US 6,312,393 B1
Filed 02/29/2000
|
Current Assignee
Geelux Holdings Ltd.
|
Sponsoring Entity
Abreu Marcio Marc A. M.
|
Apparatus for determining concentrations of hemoglobins | ||
Patent #
US 20010044700A1
Filed 11/30/2000
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Method and apparatus for non-invasive blood constituent monitoring | ||
Patent #
US 20010039376A1
Filed 01/30/2001
|
Current Assignee
Hema Metrics LLC
|
Sponsoring Entity
Hema Metrics LLC
|
Manual and automatic probe calibration | ||
Patent #
US 6,011,986 A
Filed 02/02/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Non-invasive blood component analyzer | ||
Patent #
US 6,064,898 A
Filed 09/21/1998
|
Current Assignee
Essential Medical Devices
|
Sponsoring Entity
Essential Medical Devices
|
Organism state measuring device and relaxation instructing device | ||
Patent #
US 6,081,742 A
Filed 08/04/1998
|
Current Assignee
Seiko Epson Corporation
|
Sponsoring Entity
Seiko Epson Corporation
|
Low noise optical probe | ||
Patent #
US 6,088,607 A
Filed 01/28/1997
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Methods and apparatus for estimating a physiological parameter using transforms | ||
Patent #
US 6,094,592 A
Filed 05/26/1998
|
Current Assignee
Covidien PLC
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions | ||
Patent #
US 6,120,460 A
Filed 11/02/1998
|
Current Assignee
Geelux Holdings Ltd.
|
Sponsoring Entity
Marcio Marc Abreu
|
Spectrophotometers with catheters for measuring internal tissue | ||
Patent #
US 6,134,460 A
Filed 10/15/1996
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NON-INVASIVE TECHNOLOGY INC.
|
Pulse oximeter probe | ||
Patent #
US 6,154,667 A
Filed 12/28/1998
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Medical telemetry system with wireless and physical communication channels | ||
Patent #
US 6,150,951 A
Filed 10/23/1998
|
Current Assignee
Agilent Technologies Incorporated
|
Sponsoring Entity
Agilent Technologies Incorporated
|
Direct to digital oximeter and method for calculating oxygenation levels | ||
Patent #
US 6,163,715 A
Filed 12/01/1998
|
Current Assignee
Indusind Bank Limited
|
Sponsoring Entity
Criticare Systems Inc.
|
Photonic molecular probe | ||
Patent #
US 5,871,442 A
Filed 05/19/1997
|
Current Assignee
XOETRONICS LLC
|
Sponsoring Entity
INTERNATIONAL DIAGNOSTIC TECHNOLOGIES INC.
|
Lateralization spectrophotometer | ||
Patent #
US 5,873,821 A
Filed 11/15/1993
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NON-INVASIVE TECHNOLOGY INC.
|
De-escalation of alarm priorities in medical devices | ||
Patent #
US 5,920,263 A
Filed 06/11/1998
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
-
|
Non-contact optical monitoring of physiological parameters | ||
Patent #
US 5,995,856 A
Filed 11/22/1995
|
Current Assignee
Nellcor Incorporated
|
Sponsoring Entity
Nellcor Incorporated
|
Pulse oximetry sensor adapter | ||
Patent #
US 5,995,855 A
Filed 02/11/1998
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Method and apparatus for accurately measuring the saturated oxygen in arterial blood by substantially eliminating noise from the measurement signal | ||
Patent #
US 5,995,859 A
Filed 11/26/1997
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Medical measurement apparatus | ||
Patent #
US 5,730,124 A
Filed 08/14/1995
|
Current Assignee
Mochida Pharmaceutical Company Limited
|
Sponsoring Entity
Mochida Pharmaceutical Company Limited
|
Manual and automatic probe calibration | ||
Patent #
US 5,758,644 A
Filed 06/07/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Low-noise optical probes | ||
Patent #
US 5,782,757 A
Filed 10/16/1995
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Pulse oximetry sensor with fiberoptic signal transmission | ||
Patent #
US 5,786,592 A
Filed 01/24/1997
|
Current Assignee
Hok Instrument AB
|
Sponsoring Entity
Hok Instrument AB
|
Spectrophotometer for measuring the metabolic condition of a subject | ||
Patent #
US 5,779,631 A
Filed 06/07/1995
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NON-INVASIVE TECHNOLOGY INC.
|
Gel pad optical sensor | ||
Patent #
US 5,830,136 A
Filed 10/31/1996
|
Current Assignee
Nellcor Puritan Bennett Incorporated
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Tonometer system for measuring intraocular pressure by applanation and/or indentation | ||
Patent #
US 5,830,139 A
Filed 09/04/1996
|
Current Assignee
Geelux Holdings Ltd.
|
Sponsoring Entity
Abreu Marcio M.
|
Direct to digital oximeter | ||
Patent #
US 5,842,981 A
Filed 07/17/1996
|
Current Assignee
Indusind Bank Limited
|
Sponsoring Entity
Criticare Systems Inc.
|
Pulsoximetry ear sensor | ||
Patent #
US 5,611,337 A
Filed 04/28/1995
|
Current Assignee
Koninklijke Philips N.V.
|
Sponsoring Entity
HP Inc.
|
Reliable noninvasive measurement of blood gases | ||
Patent #
US 5,630,413 A
Filed 08/12/1994
|
Current Assignee
Sandia Corporation
|
Sponsoring Entity
Sandia Corporation
|
Medical sensor with modulated encoding scheme | ||
Patent #
US 5,645,059 A
Filed 12/17/1993
|
Current Assignee
Nellcor Puritan Bennett Incorporated
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Method and apparatus for removing artifact and noise from pulse oximetry | ||
Patent #
US 5,645,060 A
Filed 06/14/1995
|
Current Assignee
Nellcor Puritan Bennett LLC
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Alignment guide system for transmissive pulse oximetry sensors | ||
Patent #
US 5,680,857 A
Filed 08/28/1992
|
Current Assignee
Spacelabs Healthcare Incorporated
|
Sponsoring Entity
Spacelabs Inc.
|
Method for noninvasive (in-vivo) total hemoglobin, oxyhemogolobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin concentration determination | ||
Patent #
US 5,692,503 A
Filed 03/10/1995
|
Current Assignee
Kuenstner J. Todd
|
Sponsoring Entity
Kuenstner J. Todd
|
Signal processing apparatus and method | ||
Patent #
US 5,482,036 A
Filed 05/26/1994
|
Current Assignee
Masimo Corporation
|
Sponsoring Entity
Masimo Corporation
|
Memory access control method and system for realizing the same | ||
Patent #
US 5,483,646 A
Filed 05/23/1994
|
Current Assignee
Toshiba Corporation
|
Sponsoring Entity
Toshiba Corporation
|
Noise reduction method and apparatus | ||
Patent #
US 5,521,851 A
Filed 04/26/1994
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Examination of biological tissue using frequency domain spectroscopy | ||
Patent #
US 5,553,614 A
Filed 06/14/1993
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NON-INVASIVE TECHNOLOGY INC.
|
Pathlength corrected oximeter and the like | ||
Patent #
US 5,564,417 A
Filed 03/16/1993
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NON-INVASIVE TECHNOLOGY INC.
|
Apparatus for measuring oxygen saturation | ||
Patent #
US 5,575,285 A
Filed 12/14/1994
|
Current Assignee
KOWA Company Limited
|
Sponsoring Entity
KOWA Company Limited
|
Apparatus for measuring predetermined data of living tissue | ||
Patent #
US 5,385,143 A
Filed 02/05/1993
|
Current Assignee
Nihon Kohden Corporation
|
Sponsoring Entity
Nihon Kohden Corporation
|
Flexible printed circuit sensor assembly for detecting optical pulses | ||
Patent #
US 5,390,670 A
Filed 10/20/1993
|
Current Assignee
Gould Electronics Incorporated
|
Sponsoring Entity
Gould Electronics Incorporated
|
Medical sensor | ||
Patent #
US 5,413,099 A
Filed 05/11/1993
|
Current Assignee
Koninklijke Philips N.V.
|
Sponsoring Entity
HP Inc.
|
Disposable pulse oximeter sensor | ||
Patent #
US 5,469,845 A
Filed 09/13/1993
|
Current Assignee
Nellcor Puritan Bennett Incorporated
|
Sponsoring Entity
Nellcor Puritan Bennett Incorporated
|
Non-invasive oximeter arrangement | ||
Patent #
US 5,279,295 A
Filed 11/20/1990
|
Current Assignee
US Philips Corporation
|
Sponsoring Entity
US Philips Corporation
|
Method and apparatus for diagnosis of sleep disorders | ||
Patent #
US 5,275,159 A
Filed 03/20/1992
|
Current Assignee
MAP MEDIZINTECHNIK FUR ARZT UND PATIENT GMBH
|
Sponsoring Entity
MADAUS MEDIZIN ELEKTRONIK GMBH CO. KG
|
Arterial blood monitoring probe | ||
Patent #
US 5,297,548 A
Filed 04/12/1993
|
Current Assignee
Datex-Ohmeda Incorporated
|
Sponsoring Entity
Ohmeda Inc.
|
Reliable noninvasive measurement of blood gases | ||
Patent #
US 5,355,880 A
Filed 07/06/1992
|
Current Assignee
Sandia Corporation
|
Sponsoring Entity
Sandia Corporation
|
System and method for noninvasive hematocrit monitoring | ||
Patent #
US 5,372,136 A
Filed 02/01/1993
|
Current Assignee
Fresenius Medical Care Holdings Incorporated
|
Sponsoring Entity
FRONTIER MATERIALS INC.
|
Pulse oximeter with improved accuracy and response time | ||
Patent #
US 5,190,038 A
Filed 11/01/1989
|
Current Assignee
Philips Electronics North America Corporation
|
Sponsoring Entity
NOVAMETRIX MEDICAL SYSTEMS INC.
|
Diagnostic sensor clasp utilizing a slot, pivot and spring hinge mechanism | ||
Patent #
US 5,247,931 A
Filed 09/16/1991
|
Current Assignee
Mine Safety Appliances Company
|
Sponsoring Entity
Mine Safety Appliances Company
|
Disposable pulse oximeter sensor | ||
Patent #
US 5,246,003 A
Filed 02/19/1992
|
Current Assignee
Nellcor Puritan Bennett Incorporated
|
Sponsoring Entity
Nellcor Incorporated
|
Method of making a flexible printed circuit sensor assembly for detecting optical pulses | ||
Patent #
US 5,263,244 A
Filed 04/17/1992
|
Current Assignee
Gould Electronics Incorporated
|
Sponsoring Entity
Gould Electronics Incorporated
|
Fluorescent marking liquid | ||
Patent #
US 5,084,327 A
Filed 12/18/1989
|
Current Assignee
FABER-CASTELL
|
Sponsoring Entity
FABER-CASTELL
|
Phase modulated spectrophotometry | ||
Patent #
US 5,122,974 A
Filed 09/05/1990
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NIM INCORPORATED A CORPORATION OF DELAWARE
|
Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation | ||
Patent #
US 5,119,815 A
Filed 12/21/1988
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NIM INC.
|
User-wearable hemoglobinometer for measuring the metabolic condition of a subject | ||
Patent #
US 5,167,230 A
Filed 11/07/1990
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NIM Inc.
|
Non-invasive measurement of blood glucose | ||
Patent #
US 5,028,787 A
Filed 01/19/1989
|
Current Assignee
Futrex Inc.
|
Sponsoring Entity
Futrex Inc.
|
Fingertip pulse wave sensor | ||
Patent #
US 5,065,749 A
Filed 08/31/1990
|
Current Assignee
Misawa Homes Institute of Research Development
|
Sponsoring Entity
Misawa Homes Institute of Research Development
|
Method and apparatus for detecting optical pulses | ||
Patent #
US 4,911,167 A
Filed 03/30/1988
|
Current Assignee
Nellcor Puritan Bennett Incorporated
|
Sponsoring Entity
Nellcor Incorporated
|
Method and apparatus for the automatic calibration of signals employed in oximetry | ||
Patent #
US 4,913,150 A
Filed 08/18/1986
|
Current Assignee
NELLCOR PURITAN BENNETT
|
Sponsoring Entity
Physio-Control Incorporated
|
Optical fiber transducer driving and measuring circuit and method for using same | ||
Patent #
US 4,936,679 A
Filed 11/12/1985
|
Current Assignee
DESERET MEDICAL INC. A CORP. OF DE.
|
Sponsoring Entity
DESERET MEDICAL INC. A CORP. OF DE.
|
Perinatal pulse oximetry sensor | ||
Patent #
US 4,938,218 A
Filed 10/28/1988
|
Current Assignee
Nellcor Puritan Bennett Incorporated
|
Sponsoring Entity
Nellcor Incorporated
|
Fingertip pulse wave sensor | ||
Patent #
US 4,971,062 A
Filed 03/28/1989
|
Current Assignee
MISAWA HOMES INSTITUTE OF RESEARCH AND DEVELOPMENT NO. 4-5 TAKAIDOHIGASHI 2-CHOME SUGINAMI-KU TOKYO JAPAN
|
Sponsoring Entity
MISAWA HOMES INSTITUTE OF RESEARCH AND DEVELOPMENT NO. 4-5 TAKAIDOHIGASHI 2-CHOME SUGINAMI-KU TOKYO JAPAN
|
Phase modulated spectrophotometry | ||
Patent #
US 4,972,331 A
Filed 02/06/1989
|
Current Assignee
NON-INVASIVE TECHNOLOGY INC.
|
Sponsoring Entity
NIM INC. A CORP. OF PA
|
Bio-photosensor | ||
Patent #
US 4,974,591 A
Filed 10/28/1988
|
Current Assignee
Sumitomo Electric Industries Limited
|
Sponsoring Entity
Sumitomo Electric Industries Limited
|
Pulse oximetry system | ||
Patent #
US 4,807,631 A
Filed 10/09/1987
|
Current Assignee
CRITIKON COMPANY L.L.C.
|
Sponsoring Entity
CRITIKON INC. A CORP. OF
|
Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment | ||
Patent #
US 4,805,623 A
Filed 09/04/1987
|
Current Assignee
VANDER CORPORATION A CORP. OF NORTH CAROLINA
|
Sponsoring Entity
VANDER CORPORATION A CORP. OF NORTH CAROLINA
|
Multi-wavelength oximeter having a means for disregarding a poor signal | ||
Patent #
US 4,714,341 A
Filed 02/21/1985
|
Current Assignee
Minolta Camera Kabushiki Kaisha
|
Sponsoring Entity
Minolta Camera Kabushiki Kaisha
|
OXIMETER AND METHOD FOR IN VIVO DETERMINATION OF OXYGEN SATURATION IN BLOOD USING THREE OR MORE DIFFERENT WAVELENGTHS | ||
Patent #
US 3,638,640 A
Filed 11/01/1967
|
Current Assignee
Robert F. Shaw
|
Sponsoring Entity
Robert F. Shaw
|
20 Claims
- 1. A method for processing a physiological signal, the method performed on a processing component and comprising the acts of:
independently, identifying one or more artifacts in a physiological signal and performing one or more multi-resolution decompositions on the physiological signal to generate two or more decomposition products; compensating for the one or more artifacts in the two or more decomposition products to generate modified decomposition products; generating an artifact-compensated signal based on the modified decomposition products; processing the artifact-compensated signal at a monitor to derive one or more physiological characteristics of interest; and displaying the one or more physiological characteristics on the monitor. - View Dependent Claims (2, 3, 4, 5)
- 6. A method for processing a signal using one or more of a sensor, a cable, or a monitor of a monitoring system comprising the acts of:
decomposing the signal based on at least frequency characteristics of the signal to generate a plurality of coefficients; independently processing the signal to identify one or more artifacts within the signal; setting the value of one or more coefficients corresponding to the one or more artifacts to zero to generate modified coefficients; and generating a modified signal based on the modified coefficients. - View Dependent Claims (7, 8, 9, 10, 11)
- 12. A physiological monitoring system, comprising:
a sensor configured to generate a physiological signal; a monitor configured to receive a form of the physiological signal from the sensor; and one or more processing components disposed in one of the sensor, the monitor, or in a cable connecting the sensor and the monitor, wherein the one or more processing components are configured to identify one or more artifacts in the physiological signal and, in parallel with the act of identification, to perform one or more multi-resolution decompositions on the physiological signal to generate two or more decomposition products, to modify respective values of portions of the two or more decomposition products corresponding to the identified artifacts to generate modified decomposition products, and to reconstruct the modified decomposition products to generate an artifact-compensated signal. - View Dependent Claims (13, 14, 15, 16)
- 17. A monitor, comprising:
one or more processing components configured to receive a physiological signal generated by a sensor, to identify one or more artifacts in the received physiological signal, to perform one or more wavelet decompositions on the received physiological signal to generate a plurality of wavelet coefficients in parallel with identifying the one or more artifacts, to modify values of one or more of the wavelet coefficients based on the identified artifacts to generate modified coefficients, and to reconstruct the modified decomposition products to generate an artifact-compensated signal. - View Dependent Claims (18, 19, 20)
1 Specification
This application is a continuation of U.S. application Ser. No. 11/241,509, titled “System and Method for Removing Artifacts from Waveforms” and filed Sep. 29, 2005, the disclosure of which is hereby incorporated by reference in its entirety for all purposes.
1. Field of the Invention
The present invention relates generally to the processing of waveform data and, more particularly, to the processing of waveforms associated with medical monitoring.
2. Description of the Related Art
This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present invention, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of the various aspects of the present invention. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.
In the field of medicine, doctors often desire to monitor certain physiological characteristics of their patients. Accordingly, a wide variety of devices have been developed for monitoring physiological characteristics. Such devices provide doctors and other healthcare personnel with the information they need to provide the best possible healthcare for their patients. As a result, such monitoring devices have become an indispensable part of modern medicine.
One technique for monitoring certain physiological characteristics of a patient is commonly referred to as pulse oximetry, and the devices built based upon pulse oximetry techniques are commonly referred to as pulse oximeters. Pulse oximetry may be used to measure various blood flow characteristics, such as the blood-oxygen saturation of hemoglobin in arterial blood, the volume of individual blood pulsations supplying the tissue, and/or the rate of blood pulsations corresponding to each heartbeat of a patient.
The quality of these measurements, however, may be adversely affected by a number of factors such as patient motion, subdermal physiological structures, poor sensor operation or fit, poor signal reception and transmission, and so forth. Such factors may result in a pulse oximetry signal which contains artifacts or noise or is otherwise of low or reduced quality. When processed, such a low or reduced quality signal may result in physiological measurements being reported which may not be as accurate or reliable as desired.
To address this issue of poor signal quality, newer pulse oximetry monitors and/or systems may include algorithms, circuits, or other components to reduce, remove, or otherwise compensate for artifacts within the pulse oximetry signal. Such artifact compensation techniques, however, may be unavailable to health care providers using older or less advanced equipment that is not configured for artifact compensation. Since replacing older or less advanced pulse oximetry monitors and/or systems may not be financially feasible, a health care provider may have little choice but to continue using a system or monitor that does not compensate for artifacts in the acquired signal. However, even if an artifact compensating system is available, an older or less advanced system may still be useful within a health care facility. It may, therefore, be useful to provide artifact compensation in conjunction with the use of systems otherwise not configured to compensate for noise and artifacts with the pulse oximetry signal.
Certain aspects commensurate in scope with the originally claimed invention are set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of certain forms the invention might take and that these aspects are not intended to limit the scope of the invention. Indeed, the invention may encompass a variety of aspects that may not be set forth below.
There is provided a method for processing a physiological signal, the method including the acts of: identifying one or more artifacts in a physiological signal; performing one or more multi-resolution decompositions on the physiological signal to generate two or more decomposition products; and compensating for the one or more artifacts in the two or more decomposition products to generate modified decomposition products.
There is provided one or more machine-readable media, including: a routine configured to identify one or more artifacts in a physiological signal; a routine configured to perform one or more multi-resolution decompositions on the physiological signal to generate two or more decomposition products; and a routine configured to compensate for the one or more artifacts in the two or more decomposition products to generate modified decomposition products.
There is provided a physiological monitoring system, including: a sensor configured to generate a physiological signal; and a monitor configured to receive an artifact-compensated signal derived from the physiological signal, wherein the artifact-compensated signal is generated by identifying one or more artifacts in the physiological signal, by performing one or more multi-resolution decompositions on the physiological signal to generate two or more decomposition products; by compensating for the one or more artifacts in the two or more decomposition products to generate modified decomposition products, and by reconstructing the modified decomposition products to generate the artifact-compensated signal.
There is provided a physiological sensor, including: an emitter configured to emit light; a detector configured to generate a signal in response to the emitted light; and one or more processing components configured to process the signal to generate an artifact-compensated signal.
There is provided a cable, including: one or more processing components configured to process an initial signal to generate an artifact-compensated signal.
There is provided an electronic device, including: one or more processing components configured to receive a signal generated by a physiological sensor, to process the signal to generate an artifact-compensated signal, and to transmit the artifact-compensated signal to a monitor which is not configured to perform artifact compensation
Advantages of the invention may become apparent upon reading the following detailed description and upon reference to the drawings in which:
One or more specific embodiments of the present invention will be described below. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers'"'"' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such a development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
It is desirable to provide a pulse oximeter signal (or other physiological monitor signal) from which the artifacts (such as may be generated by patient motion, subdermal physiological structures, poor sensor operation or fit, poor signal reception and transmission, and so forth) have been removed or reduced. Such a “clean” output signal may be provided as an input to a monitor or other display device which is not itself configured to compensate for signal noise or artifacts. The monitor or display device may display the clean signal or process the clean signal to generate one or more physiological characteristics of interest, such as measurements of blood oxygen level (SpO2), pulse rate, and so forth. In accordance with some aspects of the present technique, the artifact and noise compensation may be performed by processing components located on the sensor itself, on a cable disposed between the sensor and the monitor or display device, or on an intermediate device, such as a conversion unit or intermediate monitor.
Turning now to
In one embodiment, the patient monitor 12 may be a suitable pulse oximeter, such as those available from Nellcor Puritan Bennett Inc. In other embodiments, the patient monitor 12 may be a monitor suitable for measuring other physiological characteristics (such as tissue water fraction, tissue or blood carbon dioxide levels, and so forth) using spectrophotometric or other techniques. Furthermore, the monitor 12 may be a multi-purpose monitor suitable for performing pulse oximetry and/or other physiological and/or biochemical monitoring processes using data acquired via the sensor 10. Furthermore, to provide additional or enhanced functions to those performed by the monitor 12, the patient monitor 12 may be coupled to a multi-parameter patient monitor 16 via a cable 18 connected to a sensor input port and/or via a cable 20 connected to a digital communication port.
As noted above the data provided to the monitor 12 (or, alternatively, to the multi-parameter monitor 16) is generated at the sensor 10. In the example depicted in
For example, for pulse oximetry applications the oxygen saturation of the patient'"'"'s arterial blood (SaO2) may be determined using two or more wavelengths of light emitted by the emitter 22, most commonly red and near infrared wavelengths. After passage through the patient'"'"'s tissue, a portion of the light emitted at these wavelengths is detected by the detector 24. The detector generates one or more signals, such an electrical or optical signals, in response to the amount of each wavelength that is detected at a given time. The generated signals may be digital or, where acquired as analog signals, may be digitized in implementations where digital processing and manipulation of the signals is employed. Such digitalization may be performed at the monitor 12 or prior to reaching the monitor 12. The signals, as noted above, may be transmitted via the cable 14 to the monitor 12, where the oxygen saturation or other physiological characteristic is calculated based on the signals. The signals may contain artifacts due to a variety of factors, such as light modulation by subdermal anatomic structures, patient motion during data acquisition, poor sensor operation or fit, poor signal reception and transmission, and so forth.
In one implementation of the present technique, the monitor 12 is not configured to compensate for artifacts in the data signal (such as a pulse oximetry signal) provided by the sensor 10. In such an implementation, one or more of the upstream devices or structures (such as sensor 10 and/or cable 14) may be configured to process the data to compensate for artifacts and to, thereby, generate a clean signal for processing or display by the monitor 12. Similarly, in another implementation, a downstream monitor, such as multi-parameter monitor 16 or a further downstream monitor, is not configured to compensate for artifacts in the signal. In such an implementation, the upstream devices or structures that may process the signal to compensate for artifacts may include not only the sensor 10 and/or cable 14, but also the monitors 12 or 16 and/or additional intermediate cables 18, 20. Similarly, other intermediate devices or structures may be disposed between the sensor 10 and the target monitor to process the data signal to compensate for artifacts, thereby generating a clean signal.
Referring now to
While the processor component 34 may include hardware or circuitry designed to compensate for artifacts in the signal 36, the processor component 34 may also or alternately execute code or routines stored in a memory component 40 to accomplish the desired artifact compensation. The memory component 40 may be within the same device or structure as the processing component 34 or may be within a different structure or device in communication with the processing component 34. Such a memory components 40 may include solid state or integrated circuit type memory devices or other suitable memory devices, such as magnetic or optical media and/or drives suitable for use in the desired structure or device. As noted above, such processing components 34 and/or memory components 40 may be incorporated into the sensor 10, cables 14, 18, and 20, or the monitors 12, and 16.
In an embodiment of the present technique, a data signal containing artifacts is processed to compensate for those artifacts and may, subsequently, be provided to a monitor or other system that is otherwise not configured to compensate for artifacts in the signal. An example of such an embodiment is set forth in
In this example, the oximetry signals 36 are processed to identify artifacts 64 within the signal (block 62). Identification of the artifacts 64 at block 62 may be accomplished by conventional artifact identification algorithms or techniques, such as may be implemented in advanced oximetry monitors or other processor-based systems commercially available or proprietary. In accordance with the present technique, these artifact identification techniques or algorithms may be implemented, as discussed above, by one or more processing components 34. These processing components 34 may be disposed within the sensor 10 itself, within the cables 14, 18, or 20 intermediate between the sensor 10 and a target monitor, and/or within an intervening monitor, such as patient monitor 12 or multi-parameter monitor 16, or other electronic device. For example, in one embodiment, the artifact identification of block 62 includes the timing and frequency of artifacts 64. This time and frequency information may be used to locate the corresponding portion of signal components within one or more wavelet decomposition levels (as discussed below) to compensate for the respective artifacts 64.
In addition, the oximetry signals 36 may be processed using a multi-resolution decomposition technique (block 66), such as wavelet decomposition by discrete wavelet transformation using a filter bank. Though wavelet transformation is discussed generally herein, those of ordinary skill in the art will appreciate that other transformation techniques capable of providing the desired time and frequency information may also be employed and are within the scope of the present technique.
As mentioned above with regard to artifact identification, the decomposition of the signal 36 may be accomplished by suitable decomposition algorithms or techniques implemented by one or more processing components 34. These processing components 34 may be disposed within the sensor 10 itself, within the cables 14, 18, or 20 intermediate between the sensor 10 and a target monitor, and/or within an intervening monitor, such as patient monitor 12 or multi-parameter monitor 16, or other electronic device. The one or more processing components 34 that implement signal decomposition may be same or different than the processing components 34 that implement artifact identification, as discussed above. Furthermore, though
In a wavelet decomposition implementation, each iteration of decomposition yields a low-passed signal component and a high-passed signal component represented as wavelet coefficients 68. As will be appreciated by those of ordinary skill in the art, the low-passed component generally corresponds to an approximation of the signal undergoing decomposition while the high-passed component generally corresponds to detail components of the signal undergoing decomposition. In one iterative implementation, each iteration, i.e., resolution level, of the decomposition decomposes the previous approximation, i.e., low-passed component, to generate an approximation and detail component representative of the previous approximation. In other words, the low-passed component of the previous resolution level is decomposed to yield high and low-passed components at the current resolution level. Because the low-passed components are iteratively decomposed in such an implementation, each previous resolution level may be reproduced by reintegrating the low and high-passed components (i.e., the approximation and details) of the current resolution level. Similarly, the initial signal may be reproduced by reintegrating the current resolution level of approximation and details along with previous resolution levels of detail.
During or subsequent to wavelet decomposition, some or all of the high and/or low-resolution filtered components generated at some or all of the decomposition resolution levels may be processed (block 70) to compensate for artifact signal, thereby generating modified wavelet coefficients 72. For example, the timing and frequency information for the artifacts 64 identified at block 62 may be used to deduct, remove, or modify the respective wavelet decomposition coefficients, such as during signal reconstruction, to compensate for the artifacts 64. In one embodiment, artifact compensation modifies the low-passed components (i.e., approximations) and/or the high-passed components (i.e., the details) based on the frequency and/or time information associated with the identified artifacts 64 to compensate for portions of the signal attributable to the artifacts 64 in the modified coefficients 72.
For example, in one embodiment, the oximetry signal 36 undergoes a three-stage wavelet decomposition to generate the respective high and low-passed components. In this example, artifact compensation is applied to the two high-passed bands of the three-stage decomposition to generate modified coefficients in these two bands. The artifact compensation process may involve setting applicable coefficients or portions of the signal corresponding to an artifact 64 to zero or otherwise reducing the magnitude of the applicable coefficients or portions of the signal. In this manner, the level of detail in the reconstructed signal may be reduced based on the likely correspondence of the detail level to artifacts or noise instead of to physiological signal.
The modified wavelet coefficients 72 generated by artifact compensation may be reconstructed (block 74), such as by an inverse wavelet transform, to generate a clean or artifact-compensated waveform 76. In such an embodiment, the inverse wavelet transform preserves the original physiological data while allowing artifact compensation, as opposed to techniques using synthesized waveforms (such as triangular synthetic waveforms) where physiological information may be lost. This clean waveform 76, in turn, may be processed to determine (block 78) one or more physiological characteristics of interest, such as respiratory information, blood oxygen saturation, pulse rate, and so forth. In one embodiment, the clean waveform is provided to and processed by a monitor or other electronic device what is not configured to compensate for artifacts itself. Though the preceding discussion generally discusses decomposition using wavelet transformation, other decomposition techniques that generate time-frequency and/or time-scale components may also be used in accordance with the present technique.
Referring now to
While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and have been described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the following appended claims. Indeed, the present techniques may not only be applied to pulse oximetry, but also to other physiological monitor outputs as well.